Morning Trading December 10, page-492

ZLD will bounce back FA easily puts it at 14c

*Patented!, Clinically validated, Cannabis medications treating autism and insomnia, TGA approved and US licenced on the shelves selling as we speak. Also expecting to launch into the EU and UK 2021

*OTC oral heath product just released with 2 more products due 2021

*age disorders (Parkinson's) medication, due end 2020

*Vascular disease (PAD) medication due 2021

*Chronic Pain (athlete's) Product due 2021

*Dermatology (5 product's) due 2021

*Opioid Sparing medication trials due 2021

cash in the bank and only just started creating revenue
next couple 4c's will see ZLD shine, if not; well before then on more product launches. Great short to med hold.

GLTA DYOR